PFIZER INC.
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 1849-01-01
- Employees
- 88K
- Market Cap
- $163.3B
- Website
- http://www.pfizer.com
Evaluation Of Hepatic Impairment On AG-013736 Pharmacokinetics
- First Posted Date
- 2008-06-06
- Last Posted Date
- 2012-04-11
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 24
- Registration Number
- NCT00692341
- Locations
- 🇺🇸
Pfizer Investigational Site, Orlando, Florida, United States
Randomized Study Comparing the Efficacy and Safety of Varenicline Tartrate to Placebo in Smoking Cessation When Subjects Are Allowed to Set Their Own Quit Date
- First Posted Date
- 2008-06-05
- Last Posted Date
- 2015-11-20
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 659
- Registration Number
- NCT00691483
- Locations
- 🇬🇧
Pfizer Investigational Site, London, United Kingdom
Study In Patients With Overactive Bladder Treated With Toviaz® After Failure Of Previous Therapy
- First Posted Date
- 2008-06-05
- Last Posted Date
- 2018-11-02
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 823
- Registration Number
- NCT00691093
- Locations
- 🇸🇰
Pfizer Investigational Site, Zvolen, Slovakia
Comparative Study of NXL104/Ceftazidime Versus Comparator in Adults With Complicated Urinary Tract Infections
- Conditions
- Complicated Urinary Tract Infection
- Interventions
- Drug: NXL104/ceftazidimeDrug: Imipenem/Cilastatin
- First Posted Date
- 2008-06-04
- Last Posted Date
- 2018-05-25
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 137
- Registration Number
- NCT00690378
- Locations
- 🇺🇸
Four Rivers Clinical Research Inc, Paducah, Kentucky, United States
🇺🇸Summa Health System Hospitals, Akron, Ohio, United States
🇺🇸Remington-Davis, Columbus, Ohio, United States
Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study In Subjects With Osteoarthritic Pain Of The Knee
- First Posted Date
- 2008-06-03
- Last Posted Date
- 2021-07-13
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 159
- Registration Number
- NCT00689273
- Locations
- 🇺🇸
Arthritis & Rheumatic Care Center, South Miami, Florida, United States
🇺🇸Commonwealth Biomedical Research, LLC, Madisonville, Kentucky, United States
🇰🇷Severance Hospital, Yonsei University College of Medicine, Seoul, Korea, Republic of
Anidulafungin Candidemia/Invasive Candidiasis Intensive Care Study
- Conditions
- Invasive Candidiasis
- Interventions
- First Posted Date
- 2008-06-03
- Last Posted Date
- 2011-05-30
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 216
- Registration Number
- NCT00689338
- Locations
- 🇬🇧
Pfizer Investigational Site, London, United Kingdom
Comparison Of 5 CP-690,550 Doses Vs. Placebo, For The Treatment Of Rheumatoid Arthritis In Japan
- First Posted Date
- 2008-05-30
- Last Posted Date
- 2013-03-25
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 318
- Registration Number
- NCT00687193
- Locations
- 🇯🇵
Pfizer Investigational Site, Saitama, Japan
Non-Interventional Study (NIS) In Patients With Advanced And/Or Metastatic Renal Cell Carcinoma (mRCC) Treated With SUTENT®
- First Posted Date
- 2008-05-26
- Last Posted Date
- 2012-08-21
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 186
- Registration Number
- NCT00684645
- Locations
- 🇨🇿
Pfizer Investigational Site, Zlin, Czech Republic
Analgesic Efficacy And Safety of Valdecoxib For Treatment Of Post-Surgical Pain From Bunionectomy Surgery
- First Posted Date
- 2008-05-23
- Last Posted Date
- 2008-05-23
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 450
- Registration Number
- NCT00683137
- Locations
- 🇺🇸
Pfizer Investigational Site, Tacoma, Washington, United States
Post-Marketing Study Of The Safety Of Tygacil (Tigecycline)
- Conditions
- Complicated Skin and Skin Structure InfectionsComplicated Intra-abdominal Infections
- Interventions
- First Posted Date
- 2008-05-23
- Last Posted Date
- 2011-07-08
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 621
- Registration Number
- NCT00683332
- Locations
- 🇵🇭
Pfizer Investigational Site, Manila, Philippines